GSK readies for pivotal ruling in Zantac cases
FT.com
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Thursday, GSK Plc GSK resolved a U.S. lawsuit concerning its heartburn medicine Zantac shortly before the scheduled trial in..
Many stocks emerge from Wall Street's doghouse relatively quickly Wall Street’s views on stocks and sectors can change..